Universe Pharmaceuticals Inc.
UPC · NASDAQ
9/30/2024 | 9/30/2023 | 9/30/2022 | 9/30/2021 | |
|---|---|---|---|---|
| Market Cap | $890 | $3,376 | $12,047 | $46,879 |
| - Cash | $29,498 | $5,285 | $5,711 | $8,078 |
| + Debt | $7,994 | $5,482 | $3,936 | $4,334 |
| Enterprise Value | -$20,614 | $3,573 | $10,272 | $43,135 |
| Revenue | $23,024 | $32,309 | $40,143 | $47,982 |
| % Growth | -28.7% | -19.5% | -16.3% | – |
| Gross Profit | $6,072 | $10,315 | $21,891 | $25,326 |
| % Margin | 26.4% | 31.9% | 54.5% | 52.8% |
| EBITDA | -$7,357 | -$3,184 | -$6,398 | $14,196 |
| % Margin | -32% | -9.9% | -15.9% | 29.6% |
| Net Income | -$8,727 | -$6,163 | -$8,737 | $11,320 |
| % Margin | -37.9% | -19.1% | -21.8% | 23.6% |
| EPS Diluted | -1,436.12 | -1,040.53 | -1,475.02 | 2,147.18 |
| % Growth | -38% | 29.5% | -168.7% | – |
| Operating Cash Flow | -$9,507 | $1,120 | -$1,312 | -$2,056 |
| Capital Expenditures | -$363 | -$44 | -$94 | -$13,531 |
| Free Cash Flow | -$9,870 | $1,076 | -$1,406 | -$15,587 |